Doug Rimer
Plus aucun poste en cours
Profil
Doug Rimer worked as a Principal at EP Technologies, Inc. and Target Therapeutics, Inc. He then served as Vice President-West Coast Regional Operations at Boston Scientific Corp.
and Senior Vice President-Operations at Access Closure, Inc. Later, he worked as Vice President-Engineering at Invuity, Inc. and Vice President-Operations at Interventional Technologies, Inc. Finally, he served as Chief Operating Officer at Nexis Vision, Inc. Mr. Rimer completed his undergraduate degree from the University of California San Diego.
Anciens postes connus de Doug Rimer
| Sociétés | Poste | Fin |
|---|---|---|
Interventional Technologies, Inc.
 Interventional Technologies, Inc. Medical SpecialtiesHealth Technology Interventional Technologies' products are helping to combat this. The company's major contributions have been in the field of microprecision fabrication techniques as applied to cardiovascular products. Some of these include: guide catheters, guide wires, microsurgical dilatation catheters, site-specific drug delivery catheters (injecting drugs, gene therapy or radio-pharmaceuticals directly into the coronary artery wall) and a photo-mask-and-etch-on-a-tube chemical milling manufacturing process for cardiovascular stents | Directeur des opérations | - |
| EP Technologies, Inc. | Corporate Officer/Principal | - |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Target Therapeutics, Inc.
 Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Nexis Vision, Inc.
 Nexis Vision, Inc. Medical SpecialtiesHealth Technology Nexis Vision, Inc. develops ophthalmic solutions. The company was founded in 2007 and is headquartered in Menlo Park, CA. | Directeur des opérations | - |
Formation de Doug Rimer
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Invuity, Inc.
 Invuity, Inc. Medical DistributorsDistribution Services Invuity, Inc. operates as a medical technology company. The firm engages in the development and marketing of surgical and medical devices. Its products include retractors, handhelds and drop-ins under the Photonics and PhotonBlade brands. The company was founded by Kenneth B. Trauner and Alex Vayser on November 29, 2004 and is headquartered in San Francisco, CA. | Distribution Services |
Nexis Vision, Inc.
Nexis Vision, Inc. Medical SpecialtiesHealth Technology Nexis Vision, Inc. develops ophthalmic solutions. The company was founded in 2007 and is headquartered in Menlo Park, CA. | Health Technology |
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Health Technology |
Interventional Technologies, Inc.
Interventional Technologies, Inc. Medical SpecialtiesHealth Technology Interventional Technologies' products are helping to combat this. The company's major contributions have been in the field of microprecision fabrication techniques as applied to cardiovascular products. Some of these include: guide catheters, guide wires, microsurgical dilatation catheters, site-specific drug delivery catheters (injecting drugs, gene therapy or radio-pharmaceuticals directly into the coronary artery wall) and a photo-mask-and-etch-on-a-tube chemical milling manufacturing process for cardiovascular stents | Health Technology |
| EP Technologies, Inc. | Health Technology |
